Alethia Young
Research Analyst, Healthcare
About Alethia
Alethia Young, who joined William Blair in May 2026, is an analyst covering biotechnology companies. She brings 25 years of experience in the biotechnology and healthcare industry, having been a sell-side analyst, chief financial officer, and independent board member. Before William Blair, Alethia was the chief financial officer of Bicycle Therapeutics and was previously a sell-side analyst at Cantor Fitzgerald, Credit Suisse, and Deutsche Bank. She received a B.A. in economics from Duke University.
Coverage List
About William Blair
William Blair is a premier global partnership with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 30 offices worldwide.*
-
1935Year William Blair was founded
-
2,100+Employees worldwide
-
156 billion+Client assets
-
90+ YearsIndependent and employee-owned
-
30+Offices worldwide*
-
700+Companies under coverage
As of June 30, 2026
*Includes strategic alliances with Allier Capital, BDA Partners, and Poalim Equity Ltd.